QSV Equity Investors’s Labcorp LH Stock Holding History

QSV Equity Investors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$396K	Sell	1,580 -68	-4%	-$18.1K	0.59%	64
2025 Q3	$473K	Sell	1,648 -45	-3%	-$12.1K	0.48%	66
2025 Q2	$444K	Hold	1,693	–	–	0.46%	63
2025 Q1	$394K	Buy	+1,693	New	+$411K	0.41%	62
2024 Q4	–	Sell	-1,701	Closed	-$380K	–	88
2024 Q3	$380K	Buy	+1,701	New	+$374K	0.36%	64
2024 Q2	–	Sell	-1,813	Closed	-$396K	–	84
2024 Q1	$396K	Hold	1,813	–	–	0.38%	66
2023 Q4	$412K	Buy	+1,813	New	+$381K	0.4%	65

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

QSV Equity Investors's LH Position: Q4 2025 in Review

QSV Equity Investors reduced its Labcorp (LH) stake by 4.1% in Q4 2025, selling an estimated $18.1K and leaving 1,580 shares worth $396K. The position accounts for 0.59% of the portfolio, ranked #64.

QSV Equity Investors first reported a position in LH in Q4 2023 and has held it in 7 quarters since. The position peaked at $473K in Q3 2025. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.

QSV Equity Investors held 1,580 shares of Labcorp worth $396K as of Q4 2025.
QSV Equity Investors sold 68 Labcorp shares in Q4 2025, an estimated $18.1K.
Labcorp made up 0.59% of QSV Equity Investors's portfolio in Q4 2025, its #64 holding.
QSV Equity Investors first reported a position in Labcorp in Q4 2023 and has held it in 7 quarters since.
QSV Equity Investors's Labcorp position peaked at $473K in Q3 2025.
1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.